Literature DB >> 6214339

Heterogeneity of concanavalin A-induced suppressor T cells in man defined with monoclonal antibodies.

N K Damle, S Gupta.   

Abstract

Human peripheral blood T lymphocytes were enriched for OKT4+ or OKT8+ subpopulations using complement mediated lysis with OKT8 or OKT4 monoclonal antibodies. These subpopulations and unfractionated T cells were separately stimulated with concanavalin A (Con A) for a period of 48 hr and were then examined for their suppressive influence on proliferative response of autologous T cells to phytohaemagglutinin (PHA) or allogeneic non-T cells. Con A-activated unfractionated T cells, OKT4+ and OKT8+ T cell subsets markedly suppressed both these responses. Both OKT4+ and OKT8+ T cell subsets when enriched following Con A-activation of unfractionated T cells also caused significant suppression of proliferative responses of autologous T cells to PHA and allogeneic non-T cells in mixed lymphocyte cultures. The suppressive influence of Con A-activated T subsets was abolished by irradiation (2,000 rad) of activated cells. These studies indicate that Con A-induced suppressor T cells are heterogeneous. Precursors of Con A-induced suppressor T cells appear to reside in both OKT4+ and OKT8+ T cell populations.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6214339      PMCID: PMC1536612     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  21 in total

1.  Macrophage-T cell interactions in the Con A induction of human suppressive T cells.

Authors:  H V Raff; K C Cochrum; J D Stobo
Journal:  J Immunol       Date:  1978-12       Impact factor: 5.422

2.  Inhibition of humoral and cell-mediated immune responses in man by distinct suppressor cell systems.

Authors:  P I Lobo; C E Spencer
Journal:  J Clin Invest       Date:  1979-06       Impact factor: 14.808

3.  Specificity and suppressor function of human T cells responsive to autologous non-T cells.

Authors:  T Sakane; I Green
Journal:  J Immunol       Date:  1979-08       Impact factor: 5.422

4.  A monoclonal antibody with selective reactivity with functionally mature human thymocytes and all peripheral human T cells.

Authors:  E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  J Immunol       Date:  1979-09       Impact factor: 5.422

5.  Subpopulations of human T lymphocytes. II. Effect of thymopoietin, corticosteroids, and irradiation.

Authors:  S Gupta; R A Good
Journal:  Cell Immunol       Date:  1977-11       Impact factor: 4.868

6.  Fc-receptor heterogeneity of human suppressor T cells.

Authors:  A R Hayward; L Layward; P M Lydyard; L Moretta; M Dagg; A R Lawton
Journal:  J Immunol       Date:  1978-07       Impact factor: 5.422

7.  Activation of human B lymphocytes. X. Heterogeneity of concanavalin A-generated suppressor cells of the pokeweed mitogen-induced plaque-forming cell response of human peripheral blood lymphocytes.

Authors:  B F Haynes; A S Fauci
Journal:  J Immunol       Date:  1978-08       Impact factor: 5.422

8.  Concanavalin-A-induced suppressor lymphocytes in normal individuals.

Authors:  C I Smith; A Svejgaard
Journal:  Scand J Immunol       Date:  1981       Impact factor: 3.487

9.  Subpopulations of human T lymphocytes. VII. Cellular basis of concanavalin A-induced T cell-mediated suppression of immunoglobulin production by B lymphocytes from normal humans.

Authors:  S Gupta; S A Schwartz; R A Good
Journal:  Cell Immunol       Date:  1979-05       Impact factor: 4.868

10.  Suppressor cell activity after concanavalin A treatment of lymphocytes from normal donors.

Authors:  L Shou; S A Schwartz; R A Good
Journal:  J Exp Med       Date:  1976-05-01       Impact factor: 14.307

View more
  19 in total

1.  Activation of OKT4 suppressor cells in the autologous mixed lymphocyte reaction of patients with juvenile rheumatoid arthritis.

Authors:  K Oen; D Krzekotowska
Journal:  Clin Exp Immunol       Date:  1987-07       Impact factor: 4.330

2.  Suppressor-cell dysfunction in children with histiocytosis-X.

Authors:  B T Shannon; W A Newton
Journal:  J Clin Immunol       Date:  1986-11       Impact factor: 8.317

3.  In vitro induction of human suppressor T cells by mycobacterial antigens. BCG activated OKT4+ cells mediate suppression of antigen induced T cell proliferation.

Authors:  A S Mustafa; T Godal
Journal:  Clin Exp Immunol       Date:  1983-04       Impact factor: 4.330

4.  Induction of suppressor cell activities in normal lymphocytes by sera from gastric cancer patients.

Authors:  T Toge; M Tanada; K Yajima; H Kohno; E Itagaki; T Hattori
Journal:  Clin Exp Immunol       Date:  1983-10       Impact factor: 4.330

5.  Lymphocyte characteristics and function in paroxysmal nocturnal haemoglobinuria.

Authors:  E Vellenga; G J Ensing; M R Halie; C G Kallenberg; N H Mulder; H O Nieweg; T H The
Journal:  Blut       Date:  1983-08

6.  B cell activation by pokeweed mitogen in cultures of normal peripheral blood lymphocytes depleted of T regulator subsets by treatment with OKT4 and OKT8 monoclonal antibodies.

Authors:  B M Jones
Journal:  Clin Exp Immunol       Date:  1983-03       Impact factor: 4.330

7.  Antigen-induced suppression in man: non-specific suppression mediated via OKT8+ cells.

Authors:  M G Cohen; A J Munro
Journal:  Immunology       Date:  1984-08       Impact factor: 7.397

8.  B cell activity in systemic lupus erythematosus: depressed in vivo humoral immune response to a primary antigen (haemocyanin) and increased in vitro spontaneous immunoglobulin synthesis.

Authors:  C G Kallenberg; P C Limburg; C Van Slochteren; F J Van der Woude; T H The
Journal:  Clin Exp Immunol       Date:  1983-08       Impact factor: 4.330

9.  Immunoregulation in glomerulonephritis, Henoch--Schonlein purpura and lupus nephritis.

Authors:  K M Bannister; P A Drew; A R Clarkson; A J Woodroffe
Journal:  Clin Exp Immunol       Date:  1983-08       Impact factor: 4.330

10.  Studies on immunoregulatory mechanisms in acute and chronic hepatitis B.

Authors:  G Lemm; K Salzer; H Warnatz
Journal:  Clin Exp Immunol       Date:  1983-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.